EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,996,000 | -18.8% | 64,300 | +7.4% | 0.01% | 0.0% |
| Q1 2022 | $2,457,000 | -19.4% | 59,843 | -14.6% | 0.01% | -11.1% |
| Q4 2021 | $3,047,000 | +41.1% | 70,093 | +62.5% | 0.01% | +28.6% |
| Q3 2021 | $2,159,000 | -19.7% | 43,126 | +1.0% | 0.01% | -22.2% |
| Q2 2021 | $2,690,000 | +3.1% | 42,698 | +52.0% | 0.01% | 0.0% |
| Q1 2021 | $2,610,000 | -2.2% | 28,089 | -5.7% | 0.01% | 0.0% |
| Q4 2020 | $2,670,000 | -16.6% | 29,802 | -3.8% | 0.01% | -30.8% |
| Q3 2020 | $3,201,000 | +21.9% | 30,979 | -6.7% | 0.01% | +18.2% |
| Q2 2020 | $2,625,000 | +13.0% | 33,197 | -17.3% | 0.01% | 0.0% |
| Q1 2020 | $2,324,000 | +7.2% | 40,165 | 0.0% | 0.01% | +37.5% |
| Q4 2019 | $2,167,000 | -22.1% | 40,165 | -24.5% | 0.01% | -27.3% |
| Q3 2019 | $2,781,000 | – | 53,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
| Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
| AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
| PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
| SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |